Abstract
New near-infrared fluorescent agents have improved the depth sensitivity of fluorescence molecular imaging. Preliminary results from preclinical use of a near-infrared emitting, prostate cancer marker displayed adequate tumor contrast by 1 h after intravenous injection.
© 2010 Optical Society of America
PDF ArticleMore Like This
Daqing Piao, Zhen Jiang, and Gennady Slobodov
BWH3 Biomedical Optics (BIOMED) 2010
Kelsey J. Rosbach, Michelle Williams, Ann Gillenwater, and Rebecca Richards-Kortum
BWD2 Biomedical Optics (BIOMED) 2010
W. B. Wang, J. H. Ali, M. Zevallos, and R. R. Alfano
WF38 Biomedical Topical Meeting (BIOMED) 2004